Revvity Inc
(BSP:R1VT34)
R$
23.77
0 (0%)
Market Cap: 81.00 Bil
Enterprise Value: 93.46 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 65/100 PerkinElmer Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 16, 2020 / 02:05PM GMT
Release Date Price:
R$23.84
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research
Hello and good morning, everybody. I'm Derik De Bruin, the Bank of America, Life Sciences and Diagnostics tools analyst. Thank you for joining us today at our Global Healthcare Conference. With us today is a conversation with PerkinElmer. With us is Prahlad Singh, the President and CEO; and also[Bryan Kipp from IR is joining. Gentlemen, welcome.
Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director
Thank you, Derik.
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research
Thank you. Thanks for doing this. Appreciate it. A lot going on. So before we sort of dive into the endless COVID questions, which I've got a lot from investors here -- and by the way, if anyone's listening, please go ahead and send me a semi -- questions either on the Veracast link. Or if you're listening outside, go ahead and chat or e-mail.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot